Skip to main content
. Author manuscript; available in PMC: 2014 Oct 5.
Published in final edited form as: Lancet. 2013 Oct 5;382(9899):1214–1223. doi: 10.1016/S0140-6736(13)61897-8

Figure 2. Increased C7 expression and clinical benefit after blood and marrow transplantation for severe recessive dystrophic epidermolysis bullosa.

Figure 2

(A) Immune fluorescence-aided visualisation of human type VII collagen (in red) at the dermal epidermal junction before blood and marrow transplantation (top panel), 200 days after blood and marrow transplantation (middle panel), and 360 days after blood and marrow transplantation (bottom panel). Nuclei are blue (DAPI stain). (B) Clinical comparison of extremity wounds before (left panels) and after (right panels) blood and marrow transplantation. Reprinted with permission from reference 10.